Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice

Lipids in Health and Disease

Volumn 9, Issue , 2010, Pages

  Niwa, Satoru ^a   Urtz, Nicole ^a,b   Baumruker, Thomas ^a   Billich, Andreas ^a   Bornancin, Frédéric ^a  

^a Novartis Institutes for BioMedical Research Vienna   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE 1 PHOSPHATE; CERAMIDE KINASE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RAG1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; HOMEODOMAIN PROTEIN; PHOSPHOTRANSFERASE; RAG 1 PROTEIN; RAG-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH2 CELL; ANIMAL; BLOOD; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG LAVAGE; METABOLISM; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALIA; MUS;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEODOMAIN PROTEINS; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; OVALBUMIN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPLEEN; T-LYMPHOCYTES; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 76749096903     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-1     Document Type: Article

References (21)

1. Ceramide kinase, a novel lipid kinase: Molecular cloning and functional characterization. M Sugiura K Kono H Liu T Shimizugawa H Minekura S Spiegel T Kohama, Journal of Biological Chemistry 2002 277 26 23294 300 10.1074/jbc.M201535200 11956206
2. Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: Comparative analysis to glucosylceramide and sphingomyelin. A Boath C Graf E Lidome T Ullrich P Nussbaumer F Bornancin, Journal of Biological Chemistry 2008 283 13 8517 26 10.1074/jbc.M707107200 18086664
3. Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice. C Graf B Zemann P Rovina N Urtz A Schanzer R Reuschel D Mechtcheriakova M Muller E Fischer C Reichel S Huber J Dawson JG Meingassner A Billich S Niwa R Badegruber PP Van Veldhoven B Kinzel T Baumruker F Bornancin, Journal of Immunology 2008 180 5 3457 66
4. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: Antagonism by cell-permeable ceramides. A Gomez-Munoz PA Duffy A Martin L O'Brien H-S Byun R Bittman, Molecular Pharmacology 1995 47 5 883 9
5. Ceramide 1-phosphate/ceramide, a switch between life and death. A Gomez-Munoz, Biochimica et Biophysica Acta - Biomembranes 2006 1758 12 2049 56 10.1016/j.bbamem.2006.05.011 (Pubitemid 44911057)
6. Ceramide 1-Phosphate Is Required for the Translocation of Group IVA Cytosolic Phospholipase A2 and Prostaglandin Synthesis. NF Lamour P Subramanian DS Wijesinghe RV Stahelin JV Bonventre CE Chalfant, Journal of Biological Chemistry 2009 284 39 26897 907 10.1074/jbc.M109.001677 19632995
7. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. BJ Pettus A Bielawska S Spiegel P Roddy YA Hannun CE Chalfant, Journal of Biological Chemistry 2003 278 40 38206 13 10.1074/jbc.M304816200 12855693
8. Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2. BJ Pettus A Bielawska P Subramanian DS Wijesinghe M Maceyka CC Leslie JH Evans J Freiberg P Roddy YA Hannun CE Chalfant, Journal of Biological Chemistry 2004 279 12 11320 6 10.1074/jbc.M309262200 14676210
9. Anionic lipids activate group IVA cytosolic phospholipase A[2] via distinct and separate mechanisms. P Subramanian M Vora LB Gentile RV Stahelin CE Chalfant, Journal of Lipid Research 2007 48 12 2701 2708 10.1194/jlr.M700356- JLR200 17890681
10. Targeting ceramide metabolism with a potent and specific ceramide kinase inhibitor. C Graf M Klumpp M Habig P Rovina A Billich T Baumruker B Oberhauser F Bornancin, Molecular Pharmacology 2008 74 4 925 32 10.1124/mol.108.048652 18612076
11. The generation and behavioral analysis of ceramide kinase-null mice, indicating a function in cerebellar Purkinje cells. S Mitsutake U Yokose M Kato I Matsuoka J-M Yoo T-J Kim H-S Yoo Y Ando M Sugiura T Kohama Y Igarashi, Biochemical and Biophysical Research Communications 2007 363 3 519 24 10.1016/j.bbrc.2007.09.010 17888878
12. Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro. S Niwa C Graf F Bornancin, Microvascular Research 2009 77 3 389 93 10.1016/j.mvr.2009.01.006 19323974
13. Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells. Synthesis via ceramide from sphingomyelin. KA Dressler RN Kolesnick, Journal of Biological Chemistry 1990 265 25 14917 21 2394706
14. Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity. RN Kolesnick MR Hemer, Journal of Biological Chemistry 1990 265 31 18803 8 2172234
15. Ceramide does not mediate the effect of tumour necrosis factor alpha on superoxide generation in human neutrophils. F Yanaga SP Watson, Biochemical Journal 1994 298 3 733 8 8141790
16. The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. VT Hinkovska-Galcheva LA Boxer PJ Mansfield D Harsh A Blackwood JA Shayman, Journal of Biological Chemistry 1998 273 50 33203 33209 10.1074/jbc.273.50.33203 9837889
17. Ceramide Kinase Is a Mediator of Calcium-dependent Degranulation in Mast Cells. S Mitsutake T-J Kim Y Inagaki M Kato T Yamashita Y Igarashi, Journal of Biological Chemistry 2004 279 17 17570 7 10.1074/jbc.M312885200 14769792
18. Induction by antigen of intrathymic apoptosis of CD4+CD8+ TCRlo thymocytes in vivo. Kenneth M Murphy Amy B Heimberger Loh Dennis, Science 1990 250 1720 1723 10.1126/science.2125367 2125367
19. Memory T cell development in the absence of specific antigen priming. WT Lee J Cole-Calkins NE Street, J Immunol 1996 157 12 5300 7 8955176
20. Differences Between Responses of Naive and Activated T Cells to Anergy Induction. RJ Hayashi DY Loh O Kanagawa F Wang, J Immunol 1998 160 1 33 8 9551953
21. Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. B Zemann B Kinzel M Muller R Reuschel D Mechtcheriakova N Urtz F Bornancin T Baumruker A Billich, Blood 2006 107 4 1454 8 10.1182/blood-2005-07-2628 16223773